Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Institut for SchemaTerapi ApS
APS
Dissolved
CVR 42020567
Sankelmarksvej 10, 1.
Other education n.e.c. · NACE 8559
Est. 2021
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 27K
-603% vs 2023
EBITDA margin
100.0%
+603% vs 2023
Equity ratio
82.4%
Financial strength
Net profit 2024
DKK 22K
+461% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 27K
-603%
EBITDA
DKK 27K
+603%
Net profit
DKK 22K
+461%
Total assets
DKK 85K
-65%
Equity
DKK 70K
+45%
Employees
—
—
Company information
Legal name
Institut for SchemaTerapi ApS
CVR number
42020567
Legal form
Anpartsselskab
NACE code
8559 · Other education n.e.c.
Founded
11. januar 2021
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen
Contact
Address
Sankelmarksvej 10, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other education n.e.c.
Companies in Vordingborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Revenue
11
11
-5
27
Staff expenses
-0
-0
-0
-0
EBITDA
11
11
-5
27
Depreciation & amort.
-0
-0
-0
-0
EBIT
11
11
-5
27
Net financials
-1
-2
-1
-1
Profit before tax
10
9
-6
27
Tax
2
2
-0
5
Net profit
8
7
-6
22
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
262
276
244
85
Equity
48
55
49
70
Long-term debt
0
0
0
0
Short-term debt
215
221
196
15
Total debt
215
221
196
15
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2021
2024
Equity ratio
82.4%
This company
38.2%
Market median
+116% vs market
2021
2024
Return on equity
30.9%
This company
18.4%
Market median
+68% vs market
2021
2024
Net profit margin
79.3%
This company
8.1%
Market median
+879% vs market
2021
2024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
2021
2024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-11 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Susanne Vind
Individual
50.0%
50.0%
2022
Randi Meier Øibakken
Individual
100.0%
100.0%
2021
KOGNITIV PSYKIATRISK PRIVATKLINIK ApS
Company
50.0%
50.0%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Institut for SchemaTerapi ApS also hold positions in
0
other companies.
Person
Role here
Other companies